These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38995427)

  • 1. Consumers' knowledge and experiences of adverse drug reaction reporting in Australia: a national survey.
    Dedefo MG; Lim R; Kassie GM; Roughead E; Ellett LK
    Eur J Clin Pharmacol; 2024 Oct; 80(10):1543-1554. PubMed ID: 38995427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental reporting of adverse drug reactions in South Africa: An online survey.
    Pillay S; Mulubwa M; Viljoen M
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
    Katusiime B; Semakula D; Lubinga SJ
    Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey.
    Rotimi K; Fagbemi B; Omole G; Biambo AA; Ibinaiye T; Iwegbu A; Ogunmola O; Oguoma C; Oresanya O
    BMC Health Serv Res; 2024 Aug; 24(1):952. PubMed ID: 39164692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
    Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
    BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low awareness of adverse drug reaction reporting systems: a consumer survey.
    Robertson J; Newby DA
    Med J Aust; 2013 Nov; 199(10):684-6. PubMed ID: 24237099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
    Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
    Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta.
    Curtolo E; Micallef B; Szijj JV; Serracino-Inglott A; Borg JJ
    Int J Risk Saf Med; 2024; 35(3):271-286. PubMed ID: 38820023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.